Pembrolizumab Aids Survival With High-Risk Endometrial Cancer

MONDAY, Oct. 21, 2024-- Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published online Oct. 16 in the Journal of Clinical...